Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
News

National electronic disease surveillance: a dream delayed

Paul Webster
CMAJ June 11, 2013 185 (9) E365-E366; DOI: https://doi.org/10.1503/cmaj.109-4450
Paul Webster
Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

After the SARS disaster killed 44 people in Ontario in 2003, the federal government was advised by an expert panel to bolster a “system that will collect, analyze, and disseminate laboratory and health care facility data on infectious diseases and noninfectious diseases” while also extending “the business processes for infectious disease surveillance.”

To help get this monumental job done, the panel, led by Dr. David Naylor, the then-dean of medicine at the University of Toronto in Ontario, suggested Ottawa invest in electronic information systems “to enhance disease surveillance and link public health and clinical information systems.”

Ten years later, many observers give Ottawa substantial credit for extending national disease surveillance capacity, but progress has been achingly slow on developing a national electronic surveillance system, they lament.

Ottawa’s initial response to the Naylor panel’s call for a national electronic surveillance system was swift and generous. In March 2004, the federal government provided $100 million (increased to $135 million in 2007) to support the development of a pan-Canadian health surveillance system to Canada Health Infoway, a Crown corporation created in 2001 to create a national electronic health “infostructure.”

Infoway forged a collaboration with the British Columbia Ministry of Health and selected IBM to create the system, which was dubbed Panorama. IBM completed the design in 2008 and, according to the initial contract, development and implementation of the system was to be completed by 2009. But according to an audit of the project published that year, progress was delayed by numerous technical problems and confusion among the provinces — a pattern remarkably similar to the confusion and delays with Infoway’s broader efforts to create the national infostructure.

Since then, little has been seen or heard of Panorama, says Dr. Tom Noseworthy, professor of health policy and management in the Department of Community Health Sciences at the University of Calgary in Alberta.

“The concept has gone almost nowhere,” he says, while noting that Alberta opted out of Infoway’s surveillance plan from the outset.

Dr. Vivek Goel, president and CEO of the Ontario Public Health Agency, offers a more optimistic view. Despite years of delay, due largely to jurisdictional and political barriers, some parts of the Panorama system could begin functioning in Ontario in 2014, he believes, in large part because BC’s efforts to create the system are now at least starting to take a concrete form that other provinces can assess.

Figure

The hugely complex pan-Canadian surveillance system is in various phases across multiple jurisdictions.

Image courtesy of © 2013 Thinkstock

BC Ministry of Health spokeswoman Laura Neufeld says BC has been reimbursed $47.8 million for leading the development of Panorama. BC will soon implement immunization and family health components of the system, she adds, and “the final two Panorama modules — Investigations and Outbreak Management — are scheduled for release across the province a year from now.”

Outside of BC, she adds “product delivery is in various phases across multiple jurisdictions in support of the national vision of standardized public health reporting.” The system is a “public health care application” she says that will be used in public health and First Nations community clinics outside hospitals. “While deployment to hospitals is not part of the strategy at this time, it is possible if the business need arises to deploy Panorama in an acute care environment to support outbreak management,” she adds.

Goel and Noseworthy say they worry that Infoway’s decade-old technological framework for Panorama may have been overtaken by rapid technological changes.

This is a point strongly emphasized by a contractor working on the Panorama project in Toronto who spoke to CMAJ on the basis of confidentiality. “The fundamental problem with Panorama has been that Infoway insisted on integrating it into its overall master plan, which has turned out to be disastrously overly complex and unsuited to quickly meeting public health needs.”

“We’re now looking towards a world where people are working with tablets,” Goel notes, “and we’re going to see some very disruptive innovations.” At IBM Canada Ltd., Leslie Plant, external communications manager, notes that technical details regarding the Panorama system have been published on the IBM website (www-03.ibm.com/industries/ca/en/healthcare/files/panorama_application_overview_final.pdf and www-03.ibm.com/industries/ca/en/healthcare/solutions.html).

Beyond that, Plant says “IBM has no further current public information about Panorama available” and added that “Infoway really is the best source of information about where the project is today.”

For its part, Infoway did not respond to requests for interviews. A 2007 article on the Infoway website notes that SARS proved the need for Panorama to address “a really glaring example of a failure in the system” (http://v1.theglobeandmail.com/partners/free/infoway/article_sars.html).

More recent postings about Panorama on the Infoway site are now inactive.

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 185 (9)
CMAJ
Vol. 185, Issue 9
11 Jun 2013
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
National electronic disease surveillance: a dream delayed
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
National electronic disease surveillance: a dream delayed
Paul Webster
CMAJ Jun 2013, 185 (9) E365-E366; DOI: 10.1503/cmaj.109-4450

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
National electronic disease surveillance: a dream delayed
Paul Webster
CMAJ Jun 2013, 185 (9) E365-E366; DOI: 10.1503/cmaj.109-4450
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Se preparer a la prochaine pandemie en creant la << Societe canadienne de limmunisation >>
  • Preparing for the next pandemic by creating Canadian Immunization Services
  • Google Scholar

More in this TOC Section

  • Is one-way masking enough?
  • XE, XD & XF: what to know about the Omicron hybrid variants
  • 5 infectious disease topics to watch
Show more News

Similar Articles

Collections

  • Topics
    • Public health
    • Respiratory medicine

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2022, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire